Trial Profile
An oral-only, Phase 3 study of omadacycline for the treatment of acute bacterial skin and skin structure infections.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Omadacycline (Primary)
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Therapeutic Use
- 16 Jan 2017 New trial record